Stopping weight loss drugs regains weight
8 min read - fact checked (Disclaimer: Not medical advice, consult your prescribing practitioner before making any decisions) Recent systematic review and meta-analyses (1,2) suggests that cessation of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in adults with obesity and/or diabetes is commonly associated with clinically meaningful weight regain and deterioration in cardiometabolic markers (fig.1), including glycaemic control, blood pressure, and waist circumference. These findings suggest that the metabolic benefits of GLP-1RA therapy are largely treatment-dependent, a pattern consistent with other chronic disease pharmacotherapies rather than curative…......
